市場調查報告書

自調節式止痛泵(PCA泵)的全球市場:增長,趨勢,預測

Patient-controlled Analgesia Pumps Market - Growth, Trends, and Forecast

出版商 Mordor Intelligence LLP 商品編碼 964935
出版日期 內容資訊 英文 121 Pages
商品交期: 2-3個工作天內
價格
自調節式止痛泵(PCA泵)的全球市場:增長,趨勢,預測 Patient-controlled Analgesia Pumps Market - Growth, Trends, and Forecast
出版日期: 2020年08月01日內容資訊: 英文 121 Pages
簡介

在預測期內,自調節鎮痛(PCA)泵的市場規模預計將以5.2%的複合年增長率增長。市場增長的主要推動因素是慢性疼痛疾病的增加,例如類風濕關節炎,癌症和纖維肌痛。根據MD安德森癌症中心2020年1月發佈的研究報告,慢性非惡性疼痛在全世界的癌症患者中很常見,需要有效的疼痛管理治療。產品需求的增加可能是由於最近在易用性方面的進步提高了患者的滿意度並增加了無法服用口服藥物的患者的接受度。因此,上述因素可進一步刺激我們全球市場的增長。

本報告探討了自調節鎮痛(PCA)泵的全球市場,市場概況,對市場增長和障礙的分析,市場機會,按產品類型,應用,最終用戶和地區劃分的市場規模。它提供系統的信息,例如趨勢和預測,競爭情況以及主要公司的概況。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場驅動力
    • 具有增強的安全功能的技術進步
    • 慢性疼痛疾病(如癌症和關節炎)的全球患病率
  • 市場限制因素
    • 缺乏意識導致患者醫療失誤
    • 嚴格的監管框架和產品召回
  • 波特的五力分析

第5章市場細分

  • 按產品類型
    • PCA泵
    • 泵配件
  • 按應用
    • 腫瘤科
    • 糖尿病
    • 新生兒研究
    • 其他
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 家庭護理
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 南美洲

第6章競爭情況

  • 公司簡介
    • Smiths Group plc
    • Baxter International
    • Becton Dickinson
    • Fresenius Kabi
    • Micrel Medical Devices
    • Avante Health Solutions
    • B. Braun Melsungen AG
    • Ace Medical
    • Terumo Corporation
    • Abbott Laboratories
    • Pfizer Inc (Hospira)

第7章市場機會和趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 68518

The patient-controlled analgesia (PCA) pumps market studied was anticipated to grow with a CAGR of 5.2% during the forecast period. The major factors attributing to the growth of the market are a rising volume of chronic pain diseases like rheumatoid arthritis, cancer, and fibromyalgia. As per the study report published by the MD Anderson Cancer Center in January 2020, chronic non-malignant pain is common in cancer patients across the globe, necessitating effective pain management treatment. Increased demand for the products can be due to recent advancements that enhanced patient satisfaction with ease of use, and rise in adoption among patients who cannot take oral medications. Thus, the factors mentioned above are likely further to stimulate the growth of global PCA pumps market.

Key Market Trends

Oncology is Expected to Hold the Major Market Share in the Patient-controlled Analgesia Pumps Market

The oncology segment by application category is expected to account for the largest market revenue share during the forecast period. This dominance is owing to its increased usage in managing sustained cancer pain. Highly potent opioid drugs, such as hydromorphine, morphine, and fentanyl through PCA infusion, are prescribed by physicians to treat the unbearable pain. Rising adoption of PCA pumps in such conditions to improve the quality of life is expected to growth of the segment. On the other hand, the application of these products in diabetes is anticipated to witness the highest CAGR over the course of the forecast period. The lucrative growth can be attributed to a rise in the availability of products specific to diabetes, global health problems. Also, a rise in the adoption of these devices to avoid the dose dumping of pain medication is likely to propel the growth of the overall market revenue.

North America Dominates the Market and is Expected to Hold the Position During the Forecast Period.

North America is expected to dominate the overall PCA pumps market owing to the rise in the number of cases of cancer, accidental injuries, diabetes, and other ailments related to pain management. Also, the huge target elderly population during the forecast period necessitates efficient analgesic treatment due to the presence of baby boomers in the United States. As per the International Diabetes Federation in 2019, about 48 million adults in North America are living with diabetes, among which more than half of the patients are over the age of 65. Furthermore, increased health awareness among the public about pain management is also expected to propel the growth of the market in the region throughout the forecast period.

Competitive Landscape

The PCA pumps market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some prominent players are developing safe and trouble-free systems with novel technologies, while others are distributing them. Some of the companies which are currently dominating the market are Smiths Group Plc, Becton, Dickinson and Company, Fresenius SE & Co. KGaA, B. Braun Melsungen AG, and Baxter International Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Technological Advancements with Enhanced Safety Features
    • 4.2.2 Global Prevalence of Chronic Pain Diseases like Cancer and Arthritis
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness Resulting in Patient Medication Errors
    • 4.3.2 Stringent Regulatory Framework and Product Recalls
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Product Type
    • 5.1.1 PCA Pumps
    • 5.1.2 Pump Accessories
  • 5.2 Application
    • 5.2.1 Oncology
    • 5.2.2 Diabetes
    • 5.2.3 Neonatology
    • 5.2.4 Others
  • 5.3 End-users
    • 5.3.1 Hospital
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Home-care Settings
    • 5.3.4 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United states
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Smiths Group plc
    • 6.1.2 Baxter International
    • 6.1.3 Becton Dickinson
    • 6.1.4 Fresenius Kabi
    • 6.1.5 Micrel Medical Devices
    • 6.1.6 Avante Health Solutions
    • 6.1.7 B. Braun Melsungen AG
    • 6.1.8 Ace Medical
    • 6.1.9 Terumo Corporation
    • 6.1.10 Abbott Laboratories
    • 6.1.11 Pfizer Inc (Hospira)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS